RMG-I（人卵巢癌細(xì)胞）
CBP60290
詢 價(jià)
RMGI細(xì)胞全景
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Synonyms: | RMG-I |
| Profile： | Human tumor cell line from ovarian mesonephroid adenocarcinoma. |
| Background: | N/A |
| Species: | human, sapiens, Homo |
| Tissue: | ovary |
| Disease: | ovarian mesonephroid adenocarcinoma |
| Gender: | 34, female, Japanese |
| Morphology: | not informed |
| Growth Mode: | adherent |
| Doubling Time: | 60 hrs. |
| DNA Profile: | Our Cell Line Authentication Service |
| Culture Medium: |
F12+10%FBS RMG-I完全培養(yǎng)基，# CBP60290M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Methods for Passages： | Cells are subcultured after treatment with 0.02% EDTA and 2.5 % trypsin. |
| Virus Tested ： | GAPDH(+),CMV(-),EBV(-),HHV6(-),HHV7(-),BKV(-),JCV(-),ADV(-),parvoB19(-),HBV(-),HTLV1(-),HTLV2(-),HIV1(-),HIV2(-),HPV18(-) |
| Isozyme Analysis: | N/A |
| CO2 Conc. | 5% |
| Comments: | Cell culture initiated by cell dispersion culture method from suspension cells in ascites and cloned later. Passage is over 104 when deposited to the FDSC. Cells were uniqure confirmed by the STR-PCR method. For more information, please contact us (4008-750-250). |
